摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-2-(5-methyl-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide

中文名称
——
中文别名
——
英文名称
(Z)-2-(5-methyl-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide
英文别名
(Z)-2-(5-methyl-2-oxoindolin-3-ylidene)-Nphenylhydrazinecarbothioamide;1-[(5-methyl-2-oxoindol-3-yl)amino]-3-phenylthiourea
(Z)-2-(5-methyl-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide化学式
CAS
——
化学式
C16H14N4OS
mdl
——
分子量
310.379
InChiKey
KTWORJQJNNZKMT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.64
  • 重原子数:
    22.0
  • 可旋转键数:
    2.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    65.52
  • 氢给体数:
    3.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    靛红硫半脲酮衍生物的铂(II)配合物的合成:体外抗癌和脱氧核糖核酸结合活性
    摘要:
    摘要通过铂(II)与以下物质的反应,合成了六种新的具有半胱氨酸部分[PtL1至Pt(L6)2]的硫半脲席夫碱的铂(II)配合物:(Z)-2-(2-氧代吲哚- 3-亚苯基)-N-苯基肼甲硫酰胺[L1H],(Z)-2-(5-甲基-2-氧吲哚-3-亚基)-N-苯基肼甲硫酰胺[L2H],(Z)-2-(5-氟- 2-氧代吲哚-3-亚甲基)-N-苯基肼甲硫代酰胺[L3H],(Z)-N-甲基-2-(5-硝基-2-氧代吲哚-3-亚基)肼碳硫代酰胺[L4H],(Z)-N-甲基-2-(5-甲基-2-氧吲哚-3-亚甲基)肼甲硫代酰胺[L5H]和(Z)-N-乙基-2-(5-甲基-2-氧吲哚-3-亚甲基)肼甲硫代酰胺[L6H] 。这些复合物的结构通过元素分析,IR,UV-Vis,1H NMR和质谱分析进行了表征。通过单晶XRD进一步表征了Pt(L6)2的结构。这些复合物与小胸腺(CT)DNA的相互作用表现出较高的内在结合常数(Kb
    DOI:
    10.1016/j.ica.2014.03.029
  • 作为产物:
    描述:
    5-甲基靛红4-苯基-3-硫代氨基脲乙醇 为溶剂, 反应 2.0h, 以80%的产率得到(Z)-2-(5-methyl-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide
    参考文献:
    名称:
    靛红硫半脲酮衍生物的铂(II)配合物的合成:体外抗癌和脱氧核糖核酸结合活性
    摘要:
    摘要通过铂(II)与以下物质的反应,合成了六种新的具有半胱氨酸部分[PtL1至Pt(L6)2]的硫半脲席夫碱的铂(II)配合物:(Z)-2-(2-氧代吲哚- 3-亚苯基)-N-苯基肼甲硫酰胺[L1H],(Z)-2-(5-甲基-2-氧吲哚-3-亚基)-N-苯基肼甲硫酰胺[L2H],(Z)-2-(5-氟- 2-氧代吲哚-3-亚甲基)-N-苯基肼甲硫代酰胺[L3H],(Z)-N-甲基-2-(5-硝基-2-氧代吲哚-3-亚基)肼碳硫代酰胺[L4H],(Z)-N-甲基-2-(5-甲基-2-氧吲哚-3-亚甲基)肼甲硫代酰胺[L5H]和(Z)-N-乙基-2-(5-甲基-2-氧吲哚-3-亚甲基)肼甲硫代酰胺[L6H] 。这些复合物的结构通过元素分析,IR,UV-Vis,1H NMR和质谱分析进行了表征。通过单晶XRD进一步表征了Pt(L6)2的结构。这些复合物与小胸腺(CT)DNA的相互作用表现出较高的内在结合常数(Kb
    DOI:
    10.1016/j.ica.2014.03.029
点击查看最新优质反应信息

文献信息

  • Synthesis, structure and <i>in vitro</i> anticancer, DNA binding and cleavage activity of palladium (II) complexes based on isatin thiosemicarbazone derivatives
    作者:Amna Qasem Ali、Siang Guan Teoh、Naser Eltaher Eltayeb、Mohamed B. Khadeer Ahamed、A.M.S. Abdul Majid、Arabya A.A. Almutaleb
    DOI:10.1002/aoc.3813
    日期:2017.12
    Six novel palladium(II) complexes of a thiosemicarbazone Schiff base with isatin moiety (PdL1 to PdL6) were synthesized by the reaction of palladium(II) with the following: (Z)‐2‐(2‐oxoindolin‐3‐ylidene)‐N‐phenylhydrazinecarbothioamide (L1H), (Z)‐2‐(5‐methyl‐2‐oxoindolin‐3‐ylidene)‐N‐phenylhydrazinecarbothioamide (L2H), (Z)‐2‐(5‐fluoro‐2‐oxoindolin‐3‐ylidene)‐N‐phenylhydrazinecarbothioamide (L3H),
    通过钯(II)与以下物质的反应,合成了六种新颖的硫半缩胺席夫碱与isatin部分(PdL1至PdL6)的钯(II)配合物:(Z)-2-(2-氧代吲哚-3-亚吡啶)- N-苯肼基甲硫基酰胺(L1H),(Z)-2-(5-甲基-2-氧代吲哚-3-亚基)-N-苯肼基甲硫基酰胺(L2H),(Z)-2-(5-氟-2-氧代吲哚-3 -亚甲基)-N-苯基肼甲硫酰胺(L3H),(Z)-N-甲基-2-(5-硝基-2-氧代吲哚-3-亚甲基)肼甲硫酰胺(L4H),(Z)-N-甲基-2-(- 5-甲基-2-氧代吲哚-3-亚丙基)肼甲硫酰胺(L5H)和(Z)-N-乙基-2-(5-甲基-2-氧代吲哚-3-基)肼碳硫代酰胺(L6H)。这些复合物的结构使用元素分析和红外,紫外可见,1 H NMR和质谱进行了表征。使用单晶X射线衍射进一步表征了PdL5的结构。这些复合物与小牛胸腺DNA的相互作用具有很高的固有结合常数(K b
  • Synthesis of isatin thiosemicarbazones derivatives: In vitro anti-cancer, DNA binding and cleavage activities
    作者:Amna Qasem Ali、Siang Guan Teoh、Abdussalam Salhin、Naser Eltaher Eltayeb、Mohamed B. Khadeer Ahamed、A.M.S. Abdul Majid
    DOI:10.1016/j.saa.2014.01.086
    日期:2014.5
    New derivatives of thiosemicarbazone Schiff base with isatin moiety were synthesized L1-L6. The structures of these compounds were characterized based on the spectroscopic techniques. Compound L6 was further characterized by XRD single crystal. The interaction of these compounds with calf thymus (CT-DNA) exhibited high intrinsic binding constant (k(b) = 5.03-33.00 x 10(5) M-1) for L1-L3 and L5 and (6.14-9.47 x 10(4) M-1) for L4 and L6 which reflect intercalative activity of these compounds toward CT-DNA. This result was also confirmed by the viscosity data. The electrophoresis studies reveal the higher cleavage activity of L1-L3 than L4-L6. The in vitro anti-proliferative activity of these compounds against human colon cancer cell line (HCT 116) revealed that the synthesized compounds (L3, L6 and L2) exhibited good anticancer potency. (C) 2014 Elsevier B.V. All rights reserved.
  • Synthesis of nickel(II) complexes of isatin thiosemicarbazone derivatives: <i>in vitro</i> anti-cancer, DNA binding, and cleavage activities
    作者:Amna Qasem Ali、Siang Guan Teoh、Naser Eltaher Eltayeb、Mohamed B. Khadeer Ahamed、Ams Abdul Majid
    DOI:10.1080/00958972.2014.959943
    日期:2014.10.18
    Six new nickel(II) complexes of thiosemicarbazone Schiff base with isatin moiety [Ni(L1)(2)-Ni(L6)(2)] were synthesized through reaction of Ni(II) with (Z)-2-(2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (L1H), (Z)-2-(5-methyl-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (L2H), (Z)-2-(5-fluoro-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (L3H), (Z)-N-methyl-2-(5-nitro-2-oxoindolin-3-ylidene)hydrazinecarbothioamide (L4H), (Z)-N-methyl-2-(5-methyl-2-oxoindolin-3-ylidene) hydrazinecarbothioamide (L5H), and (Z)-N-ethyl-2-(5-methyl-2-oxo-indolin-3-ylidene) hydrazinecarbothioamide (L6H). The structures of the Ni complexes were characterized through elemental analysis, infrared, and mass spectral data. The structure of the NiL2 complex was further characterized through single-crystal X-ray diffraction. The interaction of these complexes with calf thymus (CT-DNA) exhibited high intrinsic binding constants (K-b = 1.4 x 10(5)-2.4 x 10(6) M-1), which reflected their intercalative activity toward CT-DNA. This result was also confirmed by viscosity data. Electrophoresis studies revealed that these complexes could cleave the DNA through the oxidative pathway. The in vitro anti-proliferative study establishes the anticancer potency of these compounds against human colorectal carcinoma cell line.
  • Varma, Rajendra S.; Pandey, Rajnish K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1982, vol. 21, # 2, p. 157 - 159
    作者:Varma, Rajendra S.、Pandey, Rajnish K.
    DOI:——
    日期:——
  • Synthesis of copper(II) complexes of isatin thiosemicarbazone derivatives: In vitro anti-cancer, DNA binding, and cleavage activities
    作者:Amna Qasem Ali、Siang Guan Teoh、Naser Eltaher Eltayeb、Mohamed B. Khadeer Ahamed、A.M.S. Abdul Majid
    DOI:10.1016/j.poly.2014.02.025
    日期:2014.5
    Six new Cu(II) complexes of thiosemicarbazone Schiff base with isatin moiety were synthesized through the reaction of Cu(II) with (Z)-2-(2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (CuL1), (Z)-2-(5-methyl-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (CuL2), (Z)-2-(5-fluoro-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (CuL3), (Z)-N-methyl-2-(5-nitro-2-oxoindolin-3-ylidene)hydrazinecarbothioamide (CuL4), (Z)-N-methyl-2-(5-methyl-2-oxoindolin-3-ylidene) hydrazinecarbothioamide (CuL5), and (Z)-N-ethyl-2-(5-methy1-2-oxoindolin-3-ylidene)hydrazinecarbothioamide (CuL6). The structures of the Schiff bases and their copper complexes were characterized based on the elemental analysis, and on the infrared, UV-Vis, H-1 and C-13 NMR and ESI-mass spectral data. The structures of the CuL2 and CuL3 complexes were further characterized by single-crystal X-ray diffraction. The interaction of these complexes with calf thymus (CT)-DNA exhibited high intrinsic binding constant (K-b = 1.6 x 10(5)-14.6 x 10(5) M-1), which reflected intercalative activity of these complexes toward CT-DNA. This result was also confirmed by the viscosity data. Electrophoresis studies revealed that the CuL1 and CuL2 complexes were able to cleave the DNA via oxidative pathway, whereas CuL3, CuL4, CuL5, and CuL6 induced DNA cleavage via oxidative and hydrolytic pathways. The in vitro anti-proliferative study establishes the anticancer potency of these compounds against the human colorectal carcinoma cell line. (c) 2014 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物